Home > Financial Ratios > BIOCON

BIOCON
Working Capital/Sales

    Back to All Ratios
BIOCON is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks
COMMUNITY POLL
for BIOCON
Please provide your vote to see the results

BIOCON Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) -83.122.951.802.114.78

What is the latest Working Capital/Sales ratio of BIOCON ?

The latest Working Capital/Sales ratio of BIOCON is -83.12 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar2024-83.12
Mar20232.95
Mar20221.80
Mar20212.11
Mar20204.78

How is Working Capital/Sales of BIOCON Trending?

Years Working Capital/Sales % Change
Mar2024 -83.12
Negative
Mar2023 2.95
63.89
Mar2022 1.8
-14.69
Mar2021 2.11
-55.86
Mar2020 4.78 -

Other Financial Ratios of BIOCON


Compare Working Capital/Sales ratio of peers of BIOCON

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BIOCON ₹36,642.3 Cr -11.7% -8.5% 19.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹396,394.0 Cr -6.7% 2.6% 5% Stock Analytics
DIVIS LABORATORIES ₹142,920.0 Cr -6.6% -3.7% 43.8% Stock Analytics
CIPLA ₹114,383.0 Cr -5.3% -2.9% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,817.0 Cr -3.8% 1.8% 25.8% Stock Analytics
DR REDDYS LABORATORIES ₹91,385.4 Cr -4.9% -3.3% -10.2% Stock Analytics


BIOCON Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BIOCON

-11.7%

-8.5%

19.1%

SENSEX

-3.6%

-0.7%

-0.5%


You may also like the below Video Courses